Entrada Therapeutics Historical PE Ratio image   This TRDA PE ratio history page last updated 4/15/2024
Entrada Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/13/2024
12.71-0.29-1.16NA
Q3 2023
11/7/2023
16.991.024.084.2
Q2 2023
8/8/2023
15.40-0.78-3.12NA
Q1 2023
5/10/2023
11.93-0.21-0.84NA
Q4 2022
3/6/2023
10.48-0.79-3.16NA
Q3 2022
11/7/2022
19.84-0.80-3.20NA
Q2 2022
8/11/2022
12.70-0.74-2.96NA
Q1 2022
5/12/2022
6.24-0.69-2.76NA
Q4 2021
3/15/2022
8.98-0.89-3.56NA
Q3 2021
12/9/2021
21.02-9.78-39.12NA
Entrada Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/13/2024
12.71-0.29-0.26NA
Q3 2023
11/7/2023
16.991.02-0.76NA
Q2 2023
8/8/2023
15.40-0.78-2.58NA
Q1 2023
5/10/2023
11.93-0.21-2.54NA
Q4 2022
3/6/2023
10.48-0.79-3.02NA
Q3 2022
11/7/2022
19.84-0.80-3.12NA
Q2 2022
8/11/2022
12.70-0.74-12.10NA
Q1 2022
5/12/2022
6.24-0.69NANA
Q4 2021
3/15/2022
8.98-0.89NANA
Q3 2021
12/9/2021
21.02-9.78NANA
Quotes delayed 20 minutes

Email EnvelopeFree TRDA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Entrada Therapeutics (TRDA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

TRML PE Ratio History
TRVI PE Ratio History
TRVN PE Ratio History
TSBX PE Ratio History
TSHA PE Ratio History
TSVT PE Ratio History
TTNP PE Ratio History
TTOO PE Ratio History
TVTX PE Ratio History
TVTY PE Ratio History
How should the TRDA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Entrada Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this TRDA Historical PE Ratio page.

What is the average historical PE for TRDA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The TRDA historical PE ratio using the annualized quarterly earnings method works out to 4.2.

What is the average historical PE for TRDA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The TRDA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Entrada Therapeutics Historical PE Ratio information for Entrada Therapeutics' stock. The average TRDA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average TRDA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this TRDA historical PE result, against the recent PE: when this page was posted on 4/12/2024, the most recent closing price for TRDA had been 12.95, and the most recent quarterly earnings result, annualized, was 4.08. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent TRDA PE on 4/12/2024 based on annualized quarterly EPS was 3.2. Based on TRDA's history, that recent PE is low relative to the historical average, with the recent PE 23.8% lower than the historical average PE across our data set for Entrada Therapeutics.

For self directed investors doing their due diligence on TRDA or any other given stock, valuation analysis for TRDA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Entrada Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TRDA. Thanks for visiting, and the next time you need to research TRDA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: EHTH Insider Buying, AAOI Insider Buying, FTLF Historical Stock Prices.

 

Entrada Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.